EGFR amplification, phosphatase and tensin homolog (PTEN) mutation and loss, the absence of isocitrate dehydrogenase (IDH) mutations, TP53 mutations, and 1p/19q codeletion are common in patients with GBM [39]. Here, TP53 is linked to glioblastoma.